Sensydia Secures $3M NIH Grant to Advance AI-Based Cardiac Assessment Platform

/

NIH STTR Fast-Track grant helps propel Sensydia’s non-invasive CPS platform building on recent funding round

LOS ANGELES, June 05, 2023--(BUSINESS WIRE)--Non-invasive cardiac diagnostic company Sensydia announced today that it was awarded a Fast-Track Small Business grant from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH).

The award provides Sensydia with non-dilutive funding for the development and clinical testing of the machine learning algorithms for the Cardiac Performance System (CPS), designed to enable earlier detection and therapy guidance for patients with heart failure and pulmonary hypertension.

"We are honored to be a recipient of this competitive award from the NIH/NHLBI and look forward to unlocking the capabilities of AI-based cardiac assessment to provide personalized care to patients suffering from heart disease," said Aman Mahajan, MD, Sensydia Chief Medical Officer.

Click here for more…..

Syndio partners with EDGE on pay equity analysis through PayEQ tool

/

Collaboration offers compliant and scalable pay equity analysis for certification and regulatory compliance

A new partnership between Syndio and EDGE Certification is set to enhance Syndio’s flagship product, PayEQ, significantly.

The collaboration will allow customers to expedite their path to certification while promoting compliance with EDGE’s internationally recognised standards.

The move comes when companies face increasing pressure to address workplace and pay equity, enabling them to align with EU legislation and meet the requirements of various ESG indices.

DE&I heavyweights

Syndio is the world’s leading workplace equity analytics platform. EDGE, an acronym for Equity, Diversity, and Gender Equality, represents the preeminent global standard for diversity, equity, and inclusion (DE&I), focusing on gender and intersectional equity within workplaces. With over 250 large organisations in 55 countries and spanning 26 industry sectors, EDGE Certification has become widely embraced. EDGE also aligns with new EU legislation and receives frequent references from ESG indices.

Click here for more…..

Coterie Insurance Opens New Markets with AI Insights from Planck

/

Planck’s platform provides rapid insights that change the game for commercial insurance underwriting

NEW YORK, May 23, 2023 (GLOBE NEWSWIRE) -- Planck’s innovative AI platform is helping Coterie Insurance and its partners deliver instant business insurance — without taking on unanticipated risk exposure. A partnership-focused MGA, Coterie leverages data and technology to provide instant quoting and issuing of small business insurance policies.

Commercial insurance for small businesses requires expert underwriting and a thorough understanding of the unique challenges facing each business. Due to the high-risk and high-touch nature of underwriting this segment, writing small businesses has been historically unprofitable and untouchable.

“Through Coterie, our distribution partners can now access millions of small businesses because it finally makes sense to write small commercial insurance,” says Coterie Insurance Co-Founder and CEO David McFarland. “With our proprietary mix of data insights from vendors including Planck, we ask for just business name and address to deliver a bindable quote, cutting the quote to bind time by 98%.”

Click here for more…..

Sensydia raises funds to commercialise CPS cardiac assessment platform

/

The CPS platform has been designed to provide quick, safe and non-invasive cardiac performance assessment.

Sensydia has raised nearly $8m in a financing round for advancing its cardiac performance system (CPS) platform.

Led by Florida-based Orlando Health Ventures, the financing round saw participation from Frontier Venture Capital, Colle Capital and other investors.

Sensydia intends to use the funds to prepare for the commercialisation of CPS, the next-generation haemodynamic monitoring platform.

Sensydia president and CEO Anthony Arnold said: “We are thrilled to have the support of investors who share our vision for transforming heart failure management.

“This funding will enable us to accelerate our march to commercialisation by expanding development and operations for our CPS platform.”

Click here for more…..